Results 201 to 210 of about 87,432 (237)
Influence of Connective Architectures of Inlaid Weft-Knitted Spacer Fabric on Compression, Impact Force Absorption, and Vibration Isolation. [PDF]
Polymers (Basel)Yan SN, Wang YL, Yu A.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Biology of ST2: The International ST2 Consensus Panel
The American Journal of Cardiology, 2015ST2 is a member of the interleukin 1 receptor family with 2 main isoforms: transmembrane or cellular (ST2L) and soluble or circulating (sST2) forms. ST2 is the receptor of the IL-33, which is an IL-1-like cytokine that can be secreted by living cells in response to cell damage.
Domingo A, Pascual-Figal +1 more
openaire +4 more sources
The American Journal of Cardiology, 2015
In recent years, numerous studies have focused on the use of soluble ST2 (sST2) as a clinical biomarker for cardiovascular disease. However, much preclinical data points to involvement of the ST2 pathway in inflammation, and specifically in pulmonary inflammation. This report summarizes the current body of clinical data suggesting the potential role of
Ednan K, Bajwa +2 more
openaire +2 more sources
In recent years, numerous studies have focused on the use of soluble ST2 (sST2) as a clinical biomarker for cardiovascular disease. However, much preclinical data points to involvement of the ST2 pathway in inflammation, and specifically in pulmonary inflammation. This report summarizes the current body of clinical data suggesting the potential role of
Ednan K, Bajwa +2 more
openaire +2 more sources
Soluble ST2—Analytical Considerations
The American Journal of Cardiology, 2015Suppression of tumorigenicity 2 (ST2, also known as interleukin [IL]-1 receptor-like-1) is an IL-1 receptor family member with transmembrane (ST2L) and soluble isoforms (sST2). ST2L is a membrane-bound receptor, and IL-33 is the functional ligand for ST2L.
Thomas, Mueller, Allan S, Jaffe
openaire +2 more sources
Heart Failure Clinics, 2018
Suppression of tumorigenicity 2 (ST2) is a member of the interleukin (IL)-1 receptor family, whose role was originally established in the context of inflammatory and autoimmune diseases. More recently, testing for ST2 has been used in the setting of cardiovascular disease.
Cian P, McCarthy, James L, Januzzi
openaire +2 more sources
Suppression of tumorigenicity 2 (ST2) is a member of the interleukin (IL)-1 receptor family, whose role was originally established in the context of inflammatory and autoimmune diseases. More recently, testing for ST2 has been used in the setting of cardiovascular disease.
Cian P, McCarthy, James L, Januzzi
openaire +2 more sources
Clinica Chimica Acta, 2015
In addition to routine clinical laboratory tests (including natriuretic peptides and cardiac troponins), other biomarkers are gaining attention for their utility in heart failure (HF) management. Among them, soluble ST2 (sST2) a novel biomarker integrating inflammation, fibrosis, and cardiac stress has been included in the 2013 ACCF/AHA guideline for ...
Benjamin, Dieplinger, Thomas, Mueller
openaire +2 more sources
In addition to routine clinical laboratory tests (including natriuretic peptides and cardiac troponins), other biomarkers are gaining attention for their utility in heart failure (HF) management. Among them, soluble ST2 (sST2) a novel biomarker integrating inflammation, fibrosis, and cardiac stress has been included in the 2013 ACCF/AHA guideline for ...
Benjamin, Dieplinger, Thomas, Mueller
openaire +2 more sources
ST2 and Prognosis in Acutely Decompensated Heart Failure: The International ST2 Consensus Panel
The American Journal of Cardiology, 2015ST2 is a member of the interleukin (IL) 1 receptor family that exists in 2 forms, a transmembrane receptor (ST2L) and a soluble receptor (sST2). The ligand of ST2 is IL-33, known to be involved in reducing tissue fibrosis and myocyte hypertrophy in mechanically strained hearts.
Januzzi, James L. +2 more
openaire +2 more sources
ST2 Testing for Chronic Heart Failure Therapy Monitoring: The International ST2 Consensus Panel
The American Journal of Cardiology, 2015Among patients with chronic heart failure (HF), it is known that soluble concentrations of the interleukin receptor family member ST2 (sST2) are prognostic for adverse outcome, including risk for progression of HF and death. Considerably less was known about the merits of serial testing of sST2 and whether such testing provides incremental information ...
James L, Januzzi +2 more
openaire +2 more sources